Loading...
TFH lymphomas: the times they aza-changin’?
In this issue of Blood, O’Connor and colleagues(1) report a phase 1 study of romidepsin combined with oral azacytidine in patients with relapsed/refractory (R/R) lymphomas, including complete remissions among 3 patients with angioimmunoblastic T-cell lymphoma (AITL) and single patients with multiple...
Na minha lista:
| Udgivet i: | Blood |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6839955/ https://ncbi.nlm.nih.gov/pubmed/31698426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002806 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|